Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Competenze
IT
EN
☰
|
UNIFIND
uniss.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Competenze
☰
Pubblicazioni
ANNALS OF HEMATOLOGY
Rivista
Codice:
E009427
ISSN:
0939-5555
Dati Generali
Dati Generali
Pubblicazioni (14)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
Aggressive natural killer cell leukaemia with a complex karyotype: a case report
Articolo
Aggressive natural killer cell leukaemia with a complex karyotype: a case report
Articolo
Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study
Articolo
Biosimilar epoetin in elderly patients with low risk myelodisplastic syndromes improves anaemia, quality of life and brain function
Articolo
Clinical Characteristics and treatment outcome of an 86-year old patient with acute myeloid leukemia with acute promyelocytic - like morphology and uncommon RARA fusion variant
Articolo
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia
Articolo
Deciphering the prognostic significance of autoimmune disorders in myelodysplastic syndromes
Articolo
Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma
Articolo
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice
Articolo
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib
Articolo
Pseudothrombocytopenia in a patient receiving romiplostim for immune thrombocytopenic purpura
Articolo
Rectal involvement in pre-early T acute lymphoblastic leukemia
Articolo
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors
Articolo
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
